Abbisko Cayman Toekomstige groei
Future criteriumcontroles 1/6
Abbisko Cayman's earnings are forecast to decline at 82% per annum while its annual revenue is expected to grow at 14.2% per year. EPS is expected to decline by 74.9% per annum. Return on equity is forecast to be -23.6% in 3 years.
Belangrijke informatie
-82.0%
Groei van de winst
-74.9%
Groei van de winst per aandeel
| Biotechs winstgroei | 41.8% |
| Inkomstengroei | 14.2% |
| Toekomstig rendement op eigen vermogen | -23.6% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 02 Aug 2024 |
Recente toekomstige groei-updates
Recent updates
Companies Like Abbisko Cayman (HKG:2256) Can Afford To Invest In Growth
Sep 30
Here's Why We're Not Too Worried About Abbisko Cayman's (HKG:2256) Cash Burn Situation
Apr 27An Intrinsic Calculation For Abbisko Cayman Limited (HKG:2256) Suggests It's 37% Undervalued
Jan 09Will Abbisko Cayman (HKG:2256) Spend Its Cash Wisely?
Nov 01We Think Abbisko Cayman (HKG:2256) Can Afford To Drive Business Growth
Jun 08Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 273 | -489 | -323 | N/A | 3 |
| 12/31/2025 | 279 | -443 | -12 | N/A | 3 |
| 12/31/2024 | 515 | -82 | -176 | -166 | 3 |
| 6/30/2024 | 497 | -16 | -64 | -55 | N/A |
| 3/31/2024 | 258 | -224 | -260 | -250 | N/A |
| 12/31/2023 | 19 | -432 | -457 | -445 | N/A |
| 9/30/2023 | 19 | -457 | -463 | -444 | N/A |
| 6/30/2023 | 19 | -483 | -468 | -444 | N/A |
| 3/31/2023 | 10 | -489 | -417 | -394 | N/A |
| 12/31/2022 | N/A | -496 | -367 | -344 | N/A |
| 9/30/2022 | 11 | -1,075 | -289 | -270 | N/A |
| 6/30/2022 | 23 | -1,654 | -212 | -196 | N/A |
| 3/31/2022 | 23 | -1,797 | -219 | -204 | N/A |
| 12/31/2021 | 23 | -1,810 | -182 | -170 | N/A |
| 3/31/2021 | 7 | -774 | -130 | -125 | N/A |
| 12/31/2020 | N/A | -707 | -127 | -123 | N/A |
| 12/31/2019 | 4 | -134 | -86 | -83 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: 2256 is forecast to remain unprofitable over the next 3 years.
Winst versus markt: 2256 is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: 2256 is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: 2256's revenue (14.2% per year) is forecast to grow faster than the Hong Kong market (7.8% per year).
Hoge groei-inkomsten: 2256's revenue (14.2% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: 2256 is forecast to be unprofitable in 3 years.